Strain identifier

BacDive ID: 12759

Type strain: No

Species: Pseudomonas aeruginosa

Strain Designation: Boston 41501, 41501

Strain history: CIP <- 1976, ATCC <- 1976, A. Medeiros, Boston, USA: strain 41501

NCBI tax ID(s): 1236529 (strain), 287 (species)

« Browse strain by BacDive ID »

expand / minimize allblue arrow down

Exclude non-curated data/information

Pseudomonas aeruginosa Boston 41501 is an aerobe, mesophilic, motile human pathogen that has multiple antibiotic resistances and was isolated from blood culture.

  1. antibiotic resistance
  2. motile
  3. aerobe
  4. human pathogen
  5. mesophilic
  6. 16S sequence
  7. Bacteria
  8. genome sequence
  • Availability in culture collections External linksarrow_down
  • [Ref.: #565] Culture collection no. DSM 1117, ATCC 27853, CCM 3955, CCUG 17619, CECT 108, CIP 76.110, JCM 6119, LMG 6395, NCIMB 12469, WDCM 00025, UCCCB116, LMG 18448, CCUG 1423, CCUG 7737, NCTC 12903
    [Ref.: #81968] *
    Literature: Only first 10 entries are displayed. Click here to see all.Click here to see only first 10 entries.
    arrow to sort Titlearrow to sort Authorsarrow to sort Journalarrow to sort DOIarrow to sort Yeararrow to sort
    Pathogenicity In Silico and Experimental Investigation of the Biological Potential of Some Recently Developed Carprofen Derivatives. Dumitrascu F, Udrea AM, Caira MR, Nuta DC, Limban C, Chifiriuc MC, Popa M, Bleotu C, Hanganu A, Dumitrescu D, Avram S Molecules 10.3390/molecules27092722 2022 *
    Pathogenicity Novel axially symmetric and unsymmetric silicon(IV) phthalocyanines having anti-inflammatory groups: synthesis, characterization and their biological properties. Gumusgoz Celik G, Gonca S, Sahin B, Ozdemir S, Atilla D, Gurek AG Dalton Trans 10.1039/d2dt00652a 2022 *
    Pathogenicity Investigating antimicrobial features and drug interactions of sedoanalgesics in intensive care unit: an experimental study. Unlu O, Bingul ES, Kesici S, Demirci M ADMET DMPK 10.5599/admet.1042 2021 *
    Pathogenicity Loaded n-Hydroxyapatite/SSG 3D Scaffolds as a Drug Delivery System of Nigella sativa Fractions for the Management of Local Antibacterial Infections. Dalli M, El Guerraf A, Azizi SE, Benataya K, Azghar A, Mi-Kyung J, Maleb A, Bonglee K, Gseyra N Nanomaterials (Basel) 10.3390/nano12050856 2022 *
    Enzymology Capillary Zone Electrophoresis in Tandem with Flow Cytometry in Viability Study of Various ATCC Bacterial Strains under Antibiotic Treatment. Kupczyk W, Maslak E, Railean-Plugaru V, Pomastowski P, Jackowski M, Buszewski B Int J Environ Res Public Health 10.3390/ijerph19031833 2022 *
    Pathogenicity Structural, biocompatibility, and antibacterial properties of Ge-DLC nanocomposite for biomedical applications. Arslan ME, Kurt MS, Aslan N, Kadi A, Oner S, Cobanoglu S, Yazici A J Biomed Mater Res B Appl Biomater 10.1002/jbm.b.35027 2022 *
    Pathogenicity eDNA Inactivation and Biofilm Inhibition by the PolymericBiocide Polyhexamethylene Guanidine Hydrochloride (PHMG-Cl). Moshynets OV, Baranovskyi TP, Iungin OS, Kysil NP, Metelytsia LO, Pokholenko I, Potochilova VV, Potters G, Rudnieva KL, Rymar SY, Semenyuta IV, Spiers AJ, Tarasyuk OP, Rogalsky SP Int J Mol Sci 10.3390/ijms23020731 2022 *
    Pathogenicity Phytochemical Profile, Antimicrobial, Cytotoxic, and Antioxidant Activities of Fresh and Air-Dried Satureja nabateorum Essential Oils. Al-Maharik N, Jaradat N Molecules 10.3390/molecules27010125 2021 *
    Enzymology Preventing Pseudomonas aeruginosa Biofilms on Indwelling Catheters by Surface-Bound Enzymes. Asker D, Awad TS, Raju D, Sanchez H, Lacdao I, Gilbert S, Sivarajah P, Andes DR, Sheppard DC, Howell PL, Hatton BD ACS Appl Bio Mater 10.1021/acsabm.1c00794 2021 *
    Pathogenicity Comparative Study of Antimicrobial, Anti-Inflammatory, and Antioxidant Activities of Different Parts from Pterocarpus Santalinoides l'Her. Ex. DC (Fabaceae). Ayena AC, Anani K, Dosseh K, Agbonon A, Gbeassor M Evid Based Complement Alternat Med 10.1155/2021/8938534 2021 *